873 related articles for article (PubMed ID: 23916558)
1. The role of HIF in cobalt-induced ischemic tolerance.
Jones SM; Novak AE; Elliott JP
Neuroscience; 2013 Nov; 252():420-30. PubMed ID: 23916558
[TBL] [Abstract][Full Text] [Related]
2. Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1 alpha and erythropoietin.
Li YX; Ding SJ; Xiao L; Guo W; Zhan Q
Neurosci Bull; 2008 Apr; 24(2):89-95. PubMed ID: 18369388
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model.
Ruscher K; Freyer D; Karsch M; Isaev N; Megow D; Sawitzki B; Priller J; Dirnagl U; Meisel A
J Neurosci; 2002 Dec; 22(23):10291-301. PubMed ID: 12451129
[TBL] [Abstract][Full Text] [Related]
4. Prolonged astrocyte-derived erythropoietin expression attenuates neuronal damage under hypothermic conditions.
Toriuchi K; Kakita H; Tamura T; Takeshita S; Yamada Y; Aoyama M
J Neuroinflammation; 2020 May; 17(1):141. PubMed ID: 32359362
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1α.
Ogle ME; Gu X; Espinera AR; Wei L
Neurobiol Dis; 2012 Feb; 45(2):733-42. PubMed ID: 22061780
[TBL] [Abstract][Full Text] [Related]
6. Preconditioning with the traditional Chinese medicine Huang-Lian-Jie-Du-Tang initiates HIF-1α-dependent neuroprotection against cerebral ischemia in rats.
Zhang Q; Bian H; Li Y; Guo L; Tang Y; Zhu H
J Ethnopharmacol; 2014 Jun; 154(2):443-52. PubMed ID: 24751364
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolyl-hydroxylase inhibition and chronic intermittent hypoxia on synaptic transmission and plasticity in the rat CA1 and dentate gyrus.
Wall AM; Corcoran AE; O'Halloran KD; O'Connor JJ
Neurobiol Dis; 2014 Feb; 62():8-17. PubMed ID: 24055213
[TBL] [Abstract][Full Text] [Related]
8. The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes.
Chavez JC; Baranova O; Lin J; Pichiule P
J Neurosci; 2006 Sep; 26(37):9471-81. PubMed ID: 16971531
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin.
Liu J; Narasimhan P; Yu F; Chan PH
Stroke; 2005 Jun; 36(6):1264-9. PubMed ID: 15890996
[TBL] [Abstract][Full Text] [Related]
10. Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures.
Montero M; Poulsen FR; Noraberg J; Kirkeby A; van Beek J; Leist M; Zimmer J
Exp Neurol; 2007 Mar; 204(1):106-17. PubMed ID: 17157835
[TBL] [Abstract][Full Text] [Related]
11. A role for prolyl hydroxylase domain proteins in hippocampal synaptic plasticity.
Corcoran A; Kunze R; Harney SC; Breier G; Marti HH; O'Connor JJ
Hippocampus; 2013 Oct; 23(10):861-72. PubMed ID: 23674383
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin inhibits HIF-1α expression via upregulation of PHD-2 transcription and translation in an in vitro model of hypoxia-ischemia.
Souvenir R; Flores JJ; Ostrowski RP; Manaenko A; Duris K; Tang J
Transl Stroke Res; 2014 Feb; 5(1):118-27. PubMed ID: 24323731
[TBL] [Abstract][Full Text] [Related]
13. Acute hypoxic exposure and prolyl-hydroxylase inhibition improves synaptic transmission recovery time from a subsequent hypoxic insult in rat hippocampus.
Lanigan S; Corcoran AE; Wall A; Mukandala G; O'Connor JJ
Brain Res; 2018 Dec; 1701():212-218. PubMed ID: 30244114
[TBL] [Abstract][Full Text] [Related]
14. Preconditioning protects against oxidative injury involving hypoxia-inducible factor-1 and vascular endothelial growth factor in cultured astrocytes.
Chu PW; Beart PM; Jones NM
Eur J Pharmacol; 2010 May; 633(1-3):24-32. PubMed ID: 20153315
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic neuroprotection against stroke: low-dose, prolonged treatment with deferoxamine or deferasirox establishes prolonged neuroprotection independent of HIF-1 function.
Zhao Y; Rempe DA
J Cereb Blood Flow Metab; 2011 Jun; 31(6):1412-23. PubMed ID: 21245873
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermia conditioned astrocyte-cultured medium protects neurons from ischemic injury by the up-regulation of HIF-1 alpha and the increased anti-apoptotic ability.
Du F; Wu XM; Gong Q; He X; Ke Y
Eur J Pharmacol; 2011 Sep; 666(1-3):19-25. PubMed ID: 21620821
[TBL] [Abstract][Full Text] [Related]
17. Induction of hypoxia inducible factor-1 attenuates metabolic insults induced by 3-nitropropionic acid in rat C6 glioma cells.
Yang YT; Ju TC; Yang DI
J Neurochem; 2005 May; 93(3):513-25. PubMed ID: 15836611
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin.
Prass K; Scharff A; Ruscher K; Löwl D; Muselmann C; Victorov I; Kapinya K; Dirnagl U; Meisel A
Stroke; 2003 Aug; 34(8):1981-6. PubMed ID: 12829864
[TBL] [Abstract][Full Text] [Related]
19. Prolyl hydroxylase inhibitors depend on extracellular glucose and hypoxia-inducible factor (HIF)-2alpha to inhibit cell death caused by nerve growth factor (NGF) deprivation: evidence that HIF-2alpha has a role in NGF-promoted survival of sympathetic neurons.
Lomb DJ; Desouza LA; Franklin JL; Freeman RS
Mol Pharmacol; 2009 May; 75(5):1198-209. PubMed ID: 19204094
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of deferoxamine against astrocyte death induced by modified oxygen glucose deprivation.
Zhang R; Huang Q; Zou L; Cao X; Huang H; Chu X
Brain Res; 2014 Oct; 1583():23-33. PubMed ID: 25152469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
